Research & Literature

Sickle cell disease: renal manifestations and mechanisms.

Nath KA, Hebbel RP

Nature reviews. Nephrology 2015; (11(3)):161-71 doi:10.1038/nrneph.2015.8.

How I treat and manage strokes in sickle cell disease.

Kassim AA, Galadanci NA, Pruthi S, DeBaun MR

Blood 2015; (125(22)):3401-10 doi:10.1182/blood-2014-09-551564.

Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.

Blinder MA, Duh MS, Sasane M, et al.

The Journal of emergency medicine 2015; (49(4)):513-522.e1.

[French guidelines for the management of adult sickle cell disease: 2015 update].

Habibi A, Arlet JB, Stankovic K, et al.

La Revue de medecine interne 2015; (36(5 Suppl 1)):5S3-84.

APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease From Pediatric to Adult Health Care.

Bryant R, Porter JS, Sobota A, et al.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 2015; (32(6)):355-9 doi:10.1177/1043454215591954.

Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know.

Rees AL

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 2016; (33(5)):339-44 doi:10.1177/1043454215614962.

Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.

Chirico EN, Faës C, Connes P, et al.

Sports medicine (Auckland, N.Z.) 2016; (46(5)):629-39 doi:10.1007/s40279-015-0447-z.

Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.

Tubman VN, Marshall R, Jallah W, et al.

Pediatric blood & cancer 2016; (63(4)):671-6 doi:10.1002/pbc.25875.

Management of Sickle Cell Disease: Recommendations from the 2014 Expert Panel Report.

Yawn BP, John-Sowah J

American family physician 2015; (92(12)):1069-76.

Original Research: Acute chest syndrome in sickle cell disease: Effect of genotype and asthma.

Pahl K, Mullen CA

Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):745-58 doi:10.1177/1535370216636720.

Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.

Fasano RM, Leong T, Kaushal M, et al.

Transfusion 2016; (56(7)):1707-15 doi:10.1111/trf.13558.

Sickle cell/β-thalassemia: Comparison of Sβ0 and Sβ+ Brazilian patients followed at a single institution.

Benites BD, Bastos SO, Baldanzi G, et al.

Hematology (Amsterdam, Netherlands) 2016; (21(10)):623-629 doi:10.1080/10245332.2016.1187843.

The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

DeBaun MR, Strunk RC

Lancet (London, England) 2016; (387(10037)):2545-53.

Safety and efficacy of hydroxyurea in children and adolescents with sickle/beta-thalassemia: two-year experience.

Papadopoulou E, Teli A, Theodoridou S, et al.

Hippokratia 2015; (19(2)):172-5.

Management of Sickle Cell Disease in Children.

Noronha SA, Sadreameli SC, Strouse JJ

Southern medical journal 2016; (109(9)):495-502 doi:10.14423/SMJ.0000000000000523.

Newborn screening for sickle cell disease in Jamaica: logistics and experience with umbilical cord samples.

Serjeant GR, Serjeant BE, Mason KP, et al.

Journal of community genetics 2017; (8(1)):17-22 doi:10.1007/s12687-016-0283-3.

Development of quality indicators for transition from pediatric to adult care in sickle cell disease: A modified Delphi survey of adult providers.

Sobota AE, Shah N, Mack JW

Pediatric blood & cancer 2017; (64(6)) doi:10.1002/pbc.26374.

[Acute splenic sequestration in children with sickle cell disease--an overview].

Larsson F, Åhlin A, Marshall Heyman M, Abrahamsson J

Lakartidningen 2016; (113()).

Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.

Lebensburger JD, Cutter GR, Howard TH, et al.

Pediatric nephrology (Berlin, Germany) 2017; (32(9)):1565-1573 doi:10.1007/s00467-017-3658-8.

A 5-year cost analysis of automated red cell exchange transfusion for the management of recurrent painful crises in adult patients with sickle cell disease.

Tsitsikas DA, Ekong A, Berg L, et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2017; (56(3)):466-469 doi:10.1016/j.transci.2017.05.020.

High birth prevalence of sickle cell disease in Northwestern Tanzania.

Ambrose EE, Makani J, Chami N, et al.

Pediatric blood & cancer 2018; (65(1)) doi:10.1002/pbc.26735.

Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices.

Jameel T, Baig M, Ahmed I, et al.

Pakistan journal of medical sciences 2017; (33(3)):665-669 doi:10.12669/pjms.333.12098.

Evaluation of newborn sickle cell screening programme in England: 2010-2016.

Streetly A, Sisodia R, Dick M, et al.

Archives of disease in childhood 2018; (103(7)):648-653 doi:10.1136/archdischild-2017-313213.

Acute Chest Syndrome in Children with Sickle Cell Disease.

Jain S, Bakshi N, Krishnamurti L

Pediatric allergy, immunology, and pulmonology 2017; (30(4)):191-201 doi:10.1089/ped.2017.0814.

How I manage red cell transfusions in patients with sickle cell disease.

Rees DC, Robinson S, Howard J

British journal of haematology 2018; (180(4)):607-617 doi:10.1111/bjh.15115.

Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.

Di Maggio R, Hsieh MM, Zhao X, et al.

International journal of molecular sciences 2018; (19(3)) doi:10.3390/ijms19030681.

Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition.

Rankine-Mullings AE, Morrison-Levy N, Soares D, et al.

British journal of haematology 2018; (181(2)):242-251 doi:10.1111/bjh.15162.

New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.

Allaf B, Patin F, Elion J, Couque N

Pediatric blood & cancer 2018; (65(9)):e27230 doi:10.1002/pbc.27230.

Oxygen-dependent flow of sickle trait blood as an in vitro therapeutic benchmark for sickle cell disease treatments.

Lu X, Chaudhury A, Higgins JM, Wood DK

American journal of hematology 2018; (93(10)):1227-1235 doi:10.1002/ajh.25227.

Pain Management Issues as Part of the Comprehensive Care of Patients with Sickle Cell Disease.

Lakkakula BVKS, Sahoo R, Verma H, Lakkakula S

Pain management nursing : official journal of the American Society of Pain Management Nurses 2018; (19(6)):558-572 doi:10.1016/j.pmn.2018.06.004.

Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.

Fasano RM, Meyer EK, Branscomb J, et al.

Transfusion medicine reviews 2019; (33(1)):12-23 doi:10.1016/j.tmrv.2018.07.003.

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings.

Inusa BPD, Wale A, Hassan AA, et al.

F1000Research 2018; (7()) doi:10.12688/f1000research.14589.1.

Clinical and Ophthalmic Factors Associated With the Severity of Sickle Cell Retinopathy.

Duan XJ, Lanzkron S, Linz MO, et al.

American journal of ophthalmology 2019; (197()):105-113 doi:10.1016/j.ajo.2018.09.025.

Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management.

Uwaezuoke SN, Ayuk AC, Ndu IK, et al.

Journal of pain research 2018; (11()):3141-3150 doi:10.2147/JPR.S185582.

Splenic sequestration crisis as an index manifestation of heterozygous hemoglobinopathy in an adult.

Edo-Osagie E, Enofe I, Hakeem H, et al.

Oxford medical case reports 2019; (2019(7)):omz069 doi:10.1093/omcr/omz069.

Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients.

Belisário AR, da Silva AA, Silva CV, et al.

Biomarkers in medicine 2019; (13(11)):967-987 doi:10.2217/bmm-2019-0105.

Optimal disease management and health monitoring in adults with sickle cell disease.

Howard J, Thein SL

Hematology. American Society of Hematology. Education Program 2019; (2019(1)):505-512 doi:10.1182/hematology.2019000055.

International Differences in Outpatient Pain Management: A Survey of Sickle Cell Disease.

El-Amin N, Nietert P, Kanter J

Journal of clinical medicine 2019; (8(12)) doi:10.3390/jcm8122136.

Use of an automated pyrosequencing technique for confirmation of sickle cell disease.

de Martino CC, Alencar CS, Loureiro P, et al.

PloS one 2019; (14(12)):e0216020 doi:10.1371/journal.pone.0216020.

Genotype/Phenotype Correlation of β-Thalassemia in Syrian Patients: A Cross-Sectional Study.

Shoujaa A, Moasses F, Mukhalalaty Y, et al.

Hemoglobin 2020; (44(1)):42-46 doi:10.1080/03630269.2019.1709207.

Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium.

Schlenz AM, Phillips S, Mueller M, et al.

Pediatric blood & cancer 2020; (67(4)):e28172 doi:10.1002/pbc.28172.

Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β+-Thalassemia by Newborn Screening.

Shook LM, Haygood D, Quinn CT

International journal of neonatal screening 2020; (6(1)) doi:10.3390/ijns6010007.

Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.

Elchuri SV, Williamson Lewis R, Quarmyne MO, et al.

Journal of pediatric hematology/oncology 2020; (42(7)):e575-e582 doi:10.1097/MPH.0000000000001782.

Asthma, allergic sensitization and lung function in sickle cell disease.

Angel A, Wandalsen GF, Solé D, et al.

Allergologia et immunopathologia 2020; (48(5)):450-457 doi:10.1016/j.aller.2019.12.012.

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

DeBaun MR, Jordan LC, King AA, et al.

Blood advances 2020; (4(8)):1554-1588 doi:10.1182/bloodadvances.2019001142.

Abdominal Manifestations of Sickle Cell Disease.

Kinger NP, Moreno CC, Miller FH, Mittal PK

Current problems in diagnostic radiology 2021; (50(2)):241-251 doi:10.1067/j.cpradiol.2020.05.012.

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.

John CC, Opoka RO, Latham TS, et al.

The New England journal of medicine 2020; (382(26)):2524-2533 doi:10.1056/NEJMoa2000146.

Red cell exchange for patients with sickle cell disease: an international survey of current practices.

Karafin MS, Hendrickson JE, Kim HC, et al.

Transfusion 2020; (60(7)):1424-1433 doi:10.1111/trf.15863.

Sickle cell disease in the era of precision medicine: looking to the future.

Steinberg MH, Kumar S, Murphy GJ, Vanuytsel K

Expert review of precision medicine and drug development 2019; (4(6)):357-367 doi:10.1080/23808993.2019.1688658.

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease.

Osunkwo I, Manwani D, Kanter J

Therapeutic advances in hematology 2020; (11()):2040620720955000 doi:10.1177/2040620720955000.

Splenic sequestration in the adult: cross sectional imaging appearance of an uncommon diagnosis.

Esterson YB, Sheth S, Kawamoto S

Clinical imaging 2021; (69()):369-373 doi:10.1016/j.clinimag.2020.10.016.

Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experience.

Karkoska K, Todd K, Niss O, et al.

Pediatric blood & cancer 2021; (68(6)):e29008 doi:10.1002/pbc.29008.

Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Biemond BJ, Tombak A, Kilinc Y, et al.

The Lancet. Haematology 2021; (8(5)):e334-e343 doi:10.1016/S2352-3026(21)00053-3.

Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.

Oudat RI, Abualruz HS, Al-Shiek NKA, et al.

Medical archives (Sarajevo, Bosnia and Herzegovina) 2021; (75(1)):27-30 doi:10.5455/medarh.2021.75.27-30.

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.

Zhou JR, Ridsdale R, MacNeil L, et al.

International journal of neonatal screening 2021; (7(4)) doi:10.3390/ijns7040078.

Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management.

Klings ES, Steinberg MH

Expert review of hematology 2022; (15(2)):117-125 doi:10.1080/17474086.2022.2041410.

Difficulties in the diagnosis of HbS/beta thalassemia: Really a mild disease?

Uçucu S, Karabıyık T, Azik F

Journal of medical biochemistry 2022; (41(1)):32-39 doi:10.5937/jomb0-30420.

Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Nickel RS, Maher JY, Hsieh MH, et al.

Journal of clinical medicine 2022; (11(9)) doi:10.3390/jcm11092318.

High risk and low prevalence diseases: Acute chest syndrome in sickle cell disease.

Koehl JL, Koyfman A, Hayes BD, Long B

The American journal of emergency medicine 2022; (58()):235-244 doi:10.1016/j.ajem.2022.06.018.

Value of DNA testing in the diagnosis of sickle-cell anemia in childhood in an environment with a high prevalence of other causes of anemia.

Mbayabo G, Lumbala Kabuyi P, Ngole M, et al.

Journal of clinical laboratory analysis 2022; (36(8)):e24593 doi:10.1002/jcla.24593.

Parvovirus b19 infection in children with sickle cell disease, watch out for splenomegaly! A case report.

de la Hoz JA, Otones LL, Sáenz MH, Martín MJR

African health sciences 2022; (22(1)):598-601 doi:10.4314/ahs.v22i1.69.

The prevalence of sickling abnormality in Oman: A review of relevant publications

Al-Mashaikhi N, Al-Rawas A, Wali Y, et al.

Acta bio-medica : Atenei Parmensis 2022; (93(4)):e2022289 doi:10.23750/abm.v93i4.13336.

Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Egesa WI, Nakalema G, Waibi WM, et al.

International journal of pediatrics 2022; (2022()):3885979 doi:10.1155/2022/3885979.

The Cardiopulmonary Complications of Sickle Cell Disease.

Desai AA, Machado RF, Cohen RT

Hematology/oncology clinics of North America 2022; (36(6)):1217-1237 doi:10.1016/j.hoc.2022.07.014.

Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care.

Pecker LH, Oteng-Ntim E, Nero A, et al.

The Lancet. Haematology 2023; (10(3)):e225-e234 doi:10.1016/S2352-3026(22)00353-2.

Compound Heterogeneous Sickle Cell-B+ Thalassemia Incidentally Discovered Through Cytological Examination of a Fine-Needle Aspiration Specimen from an Aneurysmal Bone Cyst in a Young Child: A Case Report.

Meliti A, Muftah S, Saleh D, Habibullah N

Cureus 2023; (15(1)):e33594 doi:10.7759/cureus.33594.

Description of a Colocated Comprehensive Care Model for People With Sickle Cell and Comorbid Pulmonary Disease.

Pugh C, Zeno RN, Stanek J, et al.

Journal of pediatric hematology/oncology 2023; (45(6)):e723-e727 doi:10.1097/MPH.0000000000002655.

Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?

Meacham LR, George S, Veludhandi A, et al.

Transplantation and cellular therapy 2023; (29(8)):531.e1-531.e4 doi:10.1016/j.jtct.2023.05.004.

Psychosocial challenges of persons with sickle cell anemia: A narrative review.

Essien EA, Winter-Eteng BF, Onukogu CU, et al.

Medicine 2023; (102(47)):e36147 doi:10.1097/MD.0000000000036147.

Clinical, laboratory, and molecular characteristics of a cohort of children with hemoglobinopathy S/beta-thalassemia.

Oliveira ÉL, Belisário AR, Silva NP, et al.

Hematology, transfusion and cell therapy 2024; (46(2)):167-175 doi:10.1016/j.htct.2023.11.002.

MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.

El Osta M, Benoist JF, Naubourg P, et al.

Clinical chemistry and laboratory medicine 2024; (62(6)):1149-1157 doi:10.1515/cclm-2023-1250.

DISPLACE study shows poor quality of transcranial doppler ultrasound for stroke risk screening in sickle cell anemia.

Davidow KA, Miller RE, Phillips SM, et al.

Blood advances 2024; (8(13)):3444-3452 doi:10.1182/bloodadvances.2024012631.

Sputum interleukin-6 level as a marker of severity during acute chest syndrome in children with sickle cell disease.

Mayrand L, Elie J, Pinhas Y, et al.

British journal of haematology 2024; (205(1)):329-334 doi:10.1111/bjh.19561.

Effects of hydroxyurea on fertility in male and female sickle cell disease patients. A systemic review and meta-analysis.

Sewaralthahab S, Alsubki LA, Alhrabi MS, Alsultan A

PloS one 2024; (19(6)):e0304241 doi:10.1371/journal.pone.0304241.

The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.

Allard P, Tagliaferri L, Weru V, et al.

European journal of haematology 2024; (113(4)):501-509 doi:10.1111/ejh.14259.

Advances in sickle cell retinopathy screening techniques, tests, and practices: A systematic review.

Cummings OW, Rahman S, Fletcher L, Scott AW

American journal of hematology 2024; (99(11)):2152-2163 doi:10.1002/ajh.27439.

Diagnostic accuracy of mean corpuscular volume in detecting coexisting iron deficiency in patients of sickle cell disorders: A hospital-based study.

Joshi M, Joshi A

Journal of family medicine and primary care 2024; (13(7)):2647-2652 doi:10.4103/jfmpc.jfmpc_1552_23.

Distinguishing Iron Deficiency Anemia From Beta-Thalassemia Trait: Comparative Analysis of CRUISE Index and Other Traditional Diagnostic Indices.

Hans A, Atreja CB, Batra N

Cureus 2024; (16(7)):e64048 doi:10.7759/cureus.64048.

Characterizing medical decision-making in sickle cell disease during childhood: Qualitative perspectives of caregivers.

Blakey AO, Amaro CM, Eilenberg JS, et al.

Pediatric blood & cancer 2024; (71(12)):e31307 doi:10.1002/pbc.31307.

Prevalence and Predictive Factors of Sickle Cell Emergencies Readmission in the Clinical Hematology Department of Dakar, Senegal.

Diallo AB, Seck M, Touré SA, et al.

Anemia 2024; (2024()):7143716 doi:10.1155/anem/7143716.

Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019.

Payne AB, Gierke R, Xing W, et al.

Pediatric blood & cancer 2025; (72(3)):e31467 doi:10.1002/pbc.31467.

Neurological management of ischemic stroke in sickle cell disease- a case report with an updated review of the literature.

Ciprietti C, Russo M, Santilli M, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(2)):993-998 doi:10.1007/s10072-024-07948-0.

Reproductive functions and fertility preservation in men with sickle cell disease.

Leblanc C, Sermondade N, Rivet-Danon D, et al.

Andrology 2025; (13(8)):2142-2149 doi:10.1111/andr.70021.

Investigation of Sickle Cell Retinopathy in Pediatric and Adolescent Patients Enrolled in a Large Cohort Study.

Smith BD, Hankins JS, Kang G, et al.

Ophthalmology 2025; (132(8)):911-920 doi:10.1016/j.ophtha.2025.03.031.

Reproductive Choices in Haemoglobinopathies: The Role of Preimplantation Genetic Testing.

Kakourou G, Vrettou C, Mamas T, Traeger-Synodinos J

Genes 2025; (16(4)) doi:10.3390/genes16040360.

Position Paper on the Management of Sickle Cell Disease in Saudi Arabia: Understanding Disease Landscape, Identifying Challenges, and Exploring Opportunities in Transfusion Therapies.

AlHumaidan H, Al Zayed A, Al Bahrani A, et al.

Journal of clinical medicine 2025; (14(10)) doi:10.3390/jcm14103494.

Reproductive function and sperm parameters in men with sickle cell disease: a systematic review.

Leblanc C, Sermondade N, Ogouma-Aworet L, et al.

Asian journal of andrology 2026; (28(2)):117-127 doi:10.4103/aja202510.

National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease.

Guarino SH, Jain A, Madisetti M, et al.

Blood advances 2025; (9(18)):4585-4591 doi:10.1182/bloodadvances.2025015909.

Ischemic Stroke as the Initial Presentation of Sickle Beta Thalassemia in an Adolescent: A Case Report.

Sinha S, Sharma J, Arun S, et al.

Cureus 2025; (17(5)):e84254 doi:10.7759/cureus.84254.

Emergency care for children with sickle cell disease: a focus on pain and fever.

Korman R, Hatabah D, Morris CR

Expert review of hematology 2025; (18(11)):899-921 doi:10.1080/17474086.2025.2538537.

A Case of Sickle Cell Beta Thalassemia and Recurrent Septicemia.

LeRoy DI, Ognjanovski E, Desai A, et al.

Cureus 2025; (17(7)):e87521 doi:10.7759/cureus.87521.

Challenges Associated with the Identification of Abnormal Hemoglobin Variants Utilizing the High-performance Liquid Chromatograph Technique: A Prospective Study in a Hospital Setting in Gujarat.

Anandani G, Motiani A, Goswami P, Sonagra A

International journal of applied & basic medical research 2025; (15(3)):197-205 doi:10.4103/ijabmr.ijabmr_70_25.

Hydroxyurea for Children with Sickle Cell Disease: A Practical Guide for Pediatric Clinicians.

Coyne F, Strouse JJ

Pediatric clinics of North America 2026; (73(1)):29-41 doi:10.1016/j.pcl.2025.08.007.

Trends in HU utilization and cerebrovascular outcomes before and after publication of the 2014 National Heart, Lung, and Blood Institute sickle cell disease guidelines.

Dain AS, Li Y, Master S, et al.

Pediatric hematology and oncology 2026; (43(1)):39-46 doi:10.1080/08880018.2025.2579978.

Effectiveness of preimplantation genetic testing in sickle cell disease: insights from a single-center experience.

Aganahi A, Souare F, Mayeur A, et al.

Journal of assisted reproduction and genetics 2026; (43(4)):1233-1242 doi:10.1007/s10815-026-03809-1.

Utility of First-Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders.

Yadav DD, Chhabra S, Hira JK, et al.

International journal of laboratory hematology 2026; (48(3)):652-657 doi:10.1111/ijlh.70079.

Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA).

Awuonda BO, Kiyaga C, Chirande L, et al.

Blood advances 2026; (10(9)):3200-3206 doi:10.1182/bloodadvances.2026019796.

High-performance liquid chromatography screening reveals HbS/β+-thalassemia double heterozygosity as a pediatric muscular dystrophy mimic.

López-Medina C, Portell-Rigo IM, González-Iribarren V, et al.

Laboratory medicine 2026; (57(3)) doi:10.1093/labmed/lmag019.

Update and review of the current medical and surgical management of sickle cell retinopathy.

Ercanbrack CW, Karimaghaei S, Badawi AH, et al.

Eye and vision (London, England) 2026; (13(1)).

Acute Chest Syndrome in Children with Sickle Cell Disease: A Narrative Review.

Ramirez V, Mercier-Ross J

Children (Basel, Switzerland) 2026; (13(5)) doi:10.3390/children13050670.

EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.

de Montalembert M, Cappellini MD, Iolascon A, et al.

HemaSphere 2026; (10(6)):e70381 doi:10.1002/hem3.70381.

Compound Heterozygous Sickle Cell-Beta Thalassemia Presenting As Chronic Hemolytic Anemia With Microcytosis and Prominent Left Ventricular Trabeculation: A Case Report.

Radhakrishnan VK, Kamanuru Govindarajulu A, Rajendran TN, et al.

Cureus 2026; (18(5)):e108797 doi:10.7759/cureus.108797.

Implementation of a comprehensive sickle cell center leads to improved access to care and decreased acute care use.

Kanter J, Plaxco A, Galadanci N, et al.

BMC health services research 2026; (26(1)).

Experiences of family building counseling and perceptions of reproductive technology among adults with sickle cell disease.

Gordon RD, Dyson K, Quaye N, et al.

PloS one 2026; (21(8)):e0355020 doi:10.1371/journal.pone.0355020.